B. Metzler seel. Sohn & Co’s Exact Sciences EXAS Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,731	Closed	-$205K	–	732
2025 Q1	$205K	Hold	4,731	–	–	﹤0.01%	732
2024 Q4	$266K	Sell	4,731 -27,463	-85%	-$1.71M	﹤0.01%	717
2024 Q3	$2.19M	Buy	+32,194	New	+$1.82M	0.02%	369
2024 Q2	–	Sell	-4,530	Closed	-$313K	–	767
2024 Q1	$313K	Hold	4,530	–	–	﹤0.01%	680
2023 Q4	$335K	Hold	4,530	–	–	﹤0.01%	656
2023 Q3	$309K	Buy	4,530 +1,004	+28%	+$85.2K	﹤0.01%	638
2023 Q2	$331K	Buy	3,526 +73	+2%	+$5.7K	﹤0.01%	633
2023 Q1	$234K	Buy	+3,453	New	+$222K	﹤0.01%	679
2022 Q2	–	Sell	-8,194	Closed	-$573K	–	737
2022 Q1	$573K	Hold	8,194	–	–	0.01%	573
2021 Q4	$638K	Buy	8,194 +2,048	+33%	+$181K	0.01%	512
2021 Q3	$587K	Buy	6,146 +3,648	+146%	+$385K	0.01%	535
2021 Q2	$311K	Buy	2,498 +134	+6%	+$16K	﹤0.01%	614
2021 Q1	$312K	Hold	2,364	–	–	0.01%	613
2020 Q4	$320K	Buy	+2,364	New	+$286K	0.01%	591

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

B. Metzler seel. Sohn & Co's EXAS Position: Q2 2025 in Review

B. Metzler seel. Sohn & Co sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 4,731 shares — an estimated $205K sold.

B. Metzler seel. Sohn & Co first reported a position in EXAS in Q4 2020 and held it in 14 quarters. The position peaked at $2.19M in Q3 2024. 559 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

B. Metzler seel. Sohn & Co reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
B. Metzler seel. Sohn & Co sold 4,731 Exact Sciences shares in Q2 2025, an estimated $205K.
B. Metzler seel. Sohn & Co first reported a position in Exact Sciences in Q4 2020 and held it in 14 quarters.
B. Metzler seel. Sohn & Co's Exact Sciences position peaked at $2.19M in Q3 2024.
559 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2025, filed 11 Aug 2025.